ライフサイエンスコーパス: prowess

1 and the biological substrate of human mental prowess".

2 in a phase III randomized controlled trial (PROWESS).

3 r sepsis in a recent phase 3 clinical trial (PROWESS).

4 unique and remarkable scope of its catalytic prowess.

5 in clinical practice differed from those in PROWESS.

6 ve site plays a major role in this enzymatic prowess.

7 represent oncogenic signaling and metastatic prowess.

8 y subjects' knowledge than by their physical prowess.

9 respectively, which may determine metastatic prowess.

10 reduction was much the same as was noted in PROWESS (0.851, 0.740-0.979), but smaller than that of p

11 In PROWESS, 4.1% (n = 65) of patients were heterozygous FV

12 4 adult patients with severe sepsis from the PROWESS and ENHANCE (a single-arm, open-label study of d

13 Diabetic EPCs have decreased migratory prowess and reduced proliferative capacity and an altere

14 how enzymes obtain their fantastic catalytic prowess, and has served as a guiding principle in drug d

15 overing how M. tuberculosis has achieved its prowess as a successful pathogen.

16 CI 35-48), and was higher than that noted in PROWESS at 31% (27-36; p<0.0001).

17 farming to population growth and to military prowess, both promoting the spread of farming as a livel

18 -mesenchymal transition (EMT) and metastatic prowess, but the underlying mechanisms are incompletely

19 hil cell line, and reduces their chemotactic prowess by causing them to pursue abnormally circuitous

20 ical practice patients compared with 2.2% of PROWESS DrotAA-treated patients with Acute Physiology an

21 tingly, old animals that maintain locomotory prowess exhibit less synaptic decline than same-age decr

22 re alive at 28 days (the end of the original PROWESS follow-up).

23 S (p=0.003), but similar to that reported in PROWESS high disease severity (p=0.073).

24 To mimic this aerial prowess in a similarly sized robot requires tiny, high-e

25 phenotype in vitro and increased metastatic prowess in vivo.

26 heir bodies; the basis for this regenerative prowess is an experimentally accessible stem cell popula

27 eased proliferation and diminished migratory prowess, largely resulting from decreased nitric oxide (

28 Instead, the roots of human cultural prowess may lie in the interplay of strategic social lea

29 This observed lack of proinflammatory prowess may reflect structural features of the lipid A,

30 Attempts to harness the catalytic prowess of biosynthetic enzyme systems, for both compoun

31 ide insecticide spinosyn A by exploiting the prowess of both chemical and enzymatic methods.

32 unction can greatly expand the computational prowess of central axons to allow for precise coordinati

33 plified scoring systems and to determine the prowess of each as a diagnostic instrument.

34 Despite the analytical prowess of flow cytometry, there are applications where

35 taC/C ratios tested, the average chemotactic prowess of individual cells (indicated by the distance a

36 This total synthesis demonstrates the prowess of metal-catalyzed transformations in complex mo

37 g of the Asn-105 that lends to the catalytic prowess of the enzyme since the organization of the subs

38 1, and 222 were utilized, and the inhibitory prowess of the heteroarotinoids was referenced to that o

39 en), was examined in a large clinical trial (PROWESS) of severe sepsis and a mouse endotoxemia model.

40 psis enrolled and treated with study drug in PROWESS, of whom 1,220 were alive at 28 days (the end of

41 was higher than the 3.5% (2.5-5.0) noted in PROWESS (p=0.003), but similar to that reported in PROWE

42 tilator use), and received DrotAA later than PROWESS patients (all p < .05).

43 as 42%, compared with 37% for DrotAA-treated PROWESS patients with Acute Physiology and Chronic Healt

44 as numerically higher than in DrotAA-treated PROWESS patients.

45 e sepsis onset was similar to DrotAA-treated PROWESS patients.

46 rum, we used stepwise logistic regression on PROWESS placebo patients to generate a predicted risk of

47 tor V Leiden survival benefit in the initial PROWESS population, and in mice, suggests that the as-ye

48 10 years and compare them with the original PROWESS results.

49 valuation of Severe Sepsis and septic Shock [PROWESS SHOCK]) failed to replicate the favorable result

50 findings were not changed by the addition of PROWESS-SHOCK results.

51 line with the PROWESS trial but not with the PROWESS-SHOCK trial.

52 d placebo in patients with Severe Sepsis and PROWESS-SHOCK, respectively).

53 d placebo in patients with Severe Sepsis and PROWESS-SHOCK, the average age of patients living at hom

54 quality of life was also seen in patients in PROWESS-SHOCK.

55 eiden carrier status in severe sepsis in the PROWESS study has been previously reported.

56 ding physicians, selected for their teaching prowess, supervised the teams throughout the workday and

57 strepha suspensa (Loew)] have greater sexual prowess than their virgin counterparts.

58 the diminution of integrative physiological prowess that occurs solely as a result of ageing, unaffe

59 In PROWESS, the vast majority were treated on day 0 or day

60 along with clinical trial databases from the PROWESS trial and a phase I human endotoxin trial evalua

61 effectiveness findings were in line with the PROWESS trial but not with the PROWESS-SHOCK trial.

62 These data suggest that strict adherence to PROWESS trial exclusion criteria would further limit ser

63 ning curve appeared to be present within the PROWESS trial such that the ability to demonstrate effic

64 educing mortality in severe sepsis patients (PROWESS trial) that gave impetus to new directions for b

65 with inclusion and exclusion criteria of the PROWESS trial, and 30-day postdischarge outcomes.

66 Leiden subgroup of patients enrolled in the PROWESS trial.

67 ein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial, but controversies about its effectivenes

68 pared with chorismate mutase whose catalytic prowess, when compared with water, originates predominan

69 that quantify career longevity, success, and prowess, which together contribute to the overall succes

70 0.979), but smaller than that of patients in PROWESS with high disease severity (0.708, 0.590-0.849).